Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population

Journal of Epidemiology

Volumn 22, Issue 5, 2012, Pages 395-401

  Otsuka, Maki ^a   Adachi, Hisashi ^a   Jacobs, David R ^b   Hirai, Yuji ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Kumagae, Shun Ichi ^a   Nanjo, Yasuki ^a   Yoshikawa, Kuniko ^a   Esaki, Eishi ^a   Kumagai, Eita ^a   Yokoi, Kanako ^a   Ogata, Kinuka ^a   Tsukagawa, Eri ^a   Kasahara, Akiko ^a   Ohbu, Kyoko ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; Cytokine; Mortality; Prospective study; Seven countries study

Indexed keywords

SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; FOLLOW UP; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; PROGNOSIS; QUESTIONNAIRE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTE GROWTH FACTOR; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; QUESTIONNAIRES; TUMOR MARKERS, BIOLOGICAL;

EID: 84864661734     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20110121     Document Type: Article

References (23)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984; 122:1450-9.
2. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA. 1986;83:6489-93.
3. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987;224:311-6.
4. Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H, et al. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem BiophysRes Commun. 1990;170:397-404.
5. Stoker M, Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta. 1991;1072: 81-102.
6. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 1991;3:67-85.
7. Edakuni G, Sasatomi E, Satoh T, Tokunaga O, Miyazaki K. Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int. 2001;51:172-8.
8. Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer. 1997; 75:673-7.
9. Niki M, Isozaki H, Toyoda M, Ishibashi T, Fujii K, Nomura E, et al. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepatogastroenterology. 1999;46:568-73.
10. Toiyama Y, Miki C, Inoue Y, Okugawa Y, Tanaka K, Kusunoki M. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer. 2009; 125:1657-62.
11. Siegfried JM, Weissfeld LA, Luketich JD, Weyant RJ, Gubish CT, Landreneau RJ. The clinical significance of hepatocyte growth factor for non-small cell lung cancer. Ann Thorac Surg. 1998;66:1915-8.
12. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 1994;54:1630-3.
13. Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, et al. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res. 1998;4:659-64.
14. Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis. 2004;176:145-9.
15. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, et al. Rapidand sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res. 1995;16:105-14.
16. Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, et al. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab. 2005;90:2927-31.
17. Koga Y, Hashimoto R, Adachi H, Tsuruta M, Tashiro T, Toshima H. Recent trends in cardiovascular disease and risk factors in the Seven Coutries Study. Lessons for science from the Seven Countries Study: A 35-year collaborative experience in cardiovascular disease epidemiology. Springer Verlag; 1994. p. 63-74.
18. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: World Health Organization; 2003.
19. Health and Welfare Statistics Association. Journal of Health and Welfare Statistics. 2009;56 (in Japanese).
20. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129:1177-80.
21. Tuck AB, Park M, Sterns EE, Boag A, Elliott BE. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol. 1996;148:225-32.
22. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992;119:629-41.
23. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA. 1993; 90:1937-41.